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2-oxoglutarate (2-OG)-dependent oxygenases have
diverse roles in human biology. The inhibition of
several 2-OG oxygenases is being targeted for ther-
apeutic intervention, including for cancer, anemia,
and ischemic diseases. We report a small-molecule
probe for 2-OG oxygenases that employs a hydroxy-
quinoline template coupled to a photoactivable
crosslinking group and an affinity-purification tag.
Following studies with recombinant proteins, the
probe was shown to crosslink to 2-OG oxygenases
in human crude cell extracts, including to proteins
at endogenous levels. This approach is useful for
inhibitor profiling, as demonstrated by crosslinking
to the histone demethylase FBXL11 (KDM2A) in
HEK293T nuclear extracts. The results also suggest
that small-molecule probes may be suitable for
substrate identification studies.
INTRODUCTION
Oxygenases that employ 2-oxoglutarate (2-OG) as a cosubstrate
and ferrous iron as a cofactor have emerged as a large enzyme
superfamily (Hausinger, 2004). In humans there are predicted to
be >60 oxygenases. To date, human oxygenases have been
found to have roles in collagen biosynthesis, fatty acid metabo-
lism, DNA/RNA repair and modifications, histone modification,
and the hypoxic response (Loenarz and Schofield, 2008).
In the hypoxic response in animals, 2-OG oxygenases play
important roles by catalyzing posttranslational hydroxylation of
the hypoxia-inducible transcription factor (HIF), which orches-
trates the expression of a large gene array. The oxygen depen-
dence of these hydroxylases is proposed to enable them to act
as oxygen sensors for the HIF system (Kaelin and Ratcliffe,
2008). trans-4-prolyl hydroxylation, catalyzed by the prolyl
hydroxylase domain-containing enzymes PHD1–3, of either of642 Chemistry & Biology 18, 642–654, May 27, 2011 ª2011 Elseviertwo prolyl residues in the oxygen-dependent degradation
domain of HIF-a signals for degradation via the proteasome.
HIF-a asparaginyl hydroxylation is catalyzed by the factor
inhibiting HIF (FIH) and reduces the interaction of HIF-awith tran-
scriptional coactivator proteins (Kaelin and Ratcliffe, 2008). The
upregulation of HIF and/or increases in its activity (through inhi-
bition of HIF hydroxylases or by other means) may be beneficial
for ischemic diseases, anemia, and gastrointestinal inflamma-
tory diseases (Nagel et al., 2010). On the other hand, the thera-
peutic inhibition of HIF through increasing HIF hydroxylase
activity (or by other means) is an approach for tumor treatment
because HIF-a expression is increased in hypoxia.
2-OG oxygenases also play roles in fatty acid metabolism,
namely in carnitine biosynthesis and chlorophyll metabolism,
and in modification of nucleic acids via N-demethylation and
t-RNA and 5-methylcytosine hydroxylation (for a review, see
Loenarz and Schofield, 2008). 2-OG oxygenases (the JmjC
family) have emerged as important in the modification of
histones by catalyzing the N-demethylation of N3-methyllysine
residues. Different human subfamilies of 2-OG-dependent
N3-lysine demethylases have been identified (Klose and Zhang,
2007), the members of which have a range of proposed roles,
including in cellular differentiation and development. Mutations
to two of the JmjC domain-containing demethylases (JARID1C
and PHF8) are associated with X-linked human mental retarda-
tion, indicating that these 2-OG oxygenases are important for
normal neuronal function (Jensen et al., 2005; Laumonnier
et al., 2005). The observation that JmjC proteins are often
deleted, translocated, mutated, and aberrantly expressed in
human cancers, and that some of these histone demethylases
regulate the proliferation of cancer cell lines, suggests that their
activation or inactivation (some are proposed to be oncoproteins
and others as tumor suppressors) contributes to tumor develop-
ment. For these reasons, the therapeutic potential of JmjC
histone demethylase inhibitors as anticancer agents is being
considered (for a review, see Spannhoff et al., 2009).
The diverse roles and substrates of 2-OG oxygenases make
functional assignation work challenging. It is desirable to
develop more efficient methods both for their identification in
different cell types and for the identification of their substrates.Ltd All rights reserved
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the use of small-molecule ‘‘chemical’’ probes based on inhibitor
templates specific for particular active sites (Kessler et al., 2001;
Evans and Cravatt, 2006; Sadaghiani et al., 2007). However, to
date, the development of compounds that are selective for
human 2-OG oxygenases over other enzyme families is at an
early stage.
Despite recent advancements inmass spectrometric (MS) and
bioinformatic methods, there remains a need to reduce the
complexity of the proteome prior to detailed proteomic analysis.
‘‘Classical’’ approaches include 2D electrophoresis, affinity
chromatography, and immunoprecipitation methods. Although
these techniques are powerful, they suffer from limitations; for
example, 2D electrophoresis is not selective from a functional
perspective and is not well suited for the analysis of lipophilic
proteins, and affinity chromatography and immunoprecipitation
methods normally require knowledge of the target proteins and
can be difficult to apply to complexes. Small-molecule-based
probes which are selective for specific protein families are
complementary to established techniques (Evans and Cravatt,
2006), and have long been used for profiling proteins, and partic-
ularly enzymes, in antibiotic research (e.g., penicillin binding
proteins). More recently, they have been shown to be useful in
profiling enzymes in eukaryotic cells. One strategy has employed
the use of irreversible inhibitors derivatized with an affinity tag
that enables efficient purification (Evans and Cravatt, 2006). A
development of this strategy employs reversible inhibitors
coupled to an affinity tag and a photoreactive group that ‘‘locks’’
the protein-inhibitor complex by irreversible crosslinking to
enable purification (Salisbury and Cravatt, 2008; Xu et al.,
2009; Fischer et al., 2010).
Here we report on the development of a small-molecule probe
for human 2-OG oxygenases (Table 1A) based on a reversibly
binding inhibitor coupled to an affinity-purification tag and a
photoreactive group. We demonstrate the viability of themethod
for identifying 2-OG oxygenases in crude cell extracts and for
profiling 2-OG oxygenase inhibitors.
RESULTS
Probe Selection
We began by preparing molecules with a common scaffold con-
sisting of a substituted phenyl azide as a photocrosslinking
group capable of forming a covalent bond with the target protein
after UV irradiation and a biotin derivative as an affinity-purifica-
tion tag (Table 1A). We chose this approach because it has been
useful in analogous studies on kinases by Koester and
coworkers (Fischer et al., 2010). We investigated two ‘‘inhibitor
templates’’ in order to achieve selective and reversible binding
to 2-OG oxygenases (selectivity function). In one series, we
generated N-oxalylglycine (NOG) derivatives because of the
close relationship of NOG with 2-OG, and because NOG/NOG
derivatives inhibit a range of 2-OG oxygenases (Rose et al.,
2010). In another series, we synthesized 8-hydroxyquinoline
(8-HQ) derivatives, because 8-HQ is a known iron chelator and
is present in inhibitors of 2-OG oxygenases, including PHD2
and FIH (Warshakoon et al., 2006; Smirnova et al., 2010) and
some histone demethylases (King et al., 2010) (Table 1A). As
for the kinase work (Fischer et al., 2010), a spacer was intro-Chemistry & Biology 18,duced between the inhibitor/selectivity function and the phenyl
azide in order to reduce potential reactions of the photocros-
slinker, with the intention of enabling crosslinking close to but
not within the inhibitor/selectivity function binding site on the
target oxygenases. Both epimers at the C-a chiral center of the
N-oxalyllysine group of the NOG-based probe were prepared,
because chirality at this center is a means of achieving selective
inhibition of some 2-OG oxygenases, including the HIF hydroxy-
lases (Tables 1A and 1B) (McDonough et al., 2005). Details of the
synthesis of the probes are given in Supplemental Experimental
Procedures available online.
We then investigated the capability of the probes to bind to re-
combinant PHD2 and JMJD2E (JMJD2E is likely not expressed,
but its catalytic domain is representative of the JMJD2 histone
demethylases). Initially, we tested for inhibition of/interaction
with PHD2 using an MS-based hydroxylation assay (Flashman
et al., 2010) and an NMR-based binding assay (Leung et al.,
2010), and for inhibition of JMJD2E using a formaldehyde dehy-
drogenase (FDH)-coupled assay (Rose et al., 2008) (Table 1B;
Figures S1A–S1C).
The two NOG-based probes were at most only weakly active
against both JMJD2E and, consistent with structural studies
(McDonough et al., 2005), PHD2 (Table 1B; Figure S1C). In
contrast, the 8-HQ derivative DR025 displayed promising
binding/inhibition of both enzymes (IC50 = 58.4 mM against
JMJD2E and KD = 17.7 mM and IC50 = 41.8 mM against PHD2),
and hence was selected for further work. In the absence of the
selectivity function, the common scaffold DR024 (see Supple-
mental Experimental Procedures) was not observed to bind to
PHD2 (NMR-based assay) and to inhibit JMJD2E (FDH-coupled
assay), andwas thereforeusedasanegativecontrol in subsequent
experiments (Table 1B). In contrast, the synthetic 8-HQ interme-
diate DR016 displayed a comparable binding/inhibition capacity
to PHD2 and JMJD2E (Table 1B). This property made this com-
pound useful for subsequent ‘‘competition’’ control experiments.
Photocrosslinking Experiments
To test the suitability of DR025 as a crosslinker, we carried out
studies with purified PHD2, using Mn(II) to substitute for Fe(II)
because the PHD2-Mn(II) complex is not catalytically active.
The extent of crosslinking was analyzed by protein MS through
the observation of a mass shift approximately corresponding
to the mass of the probe after the loss of N2. Prior to UV irradia-
tion, only a mass peak corresponding to PHD2 (28 kDa) was
observed (Figure 1Ai). After irradiation, an additional peak with
amass shift of >800Dawas observed, consistent with a covalent
adduct formation with DR025 (m/z 861 for [M-N2]) (Figure 1Aii).
The extent of crosslinking by DR025 was substantially reduced
in competition experiments (1:1 ratio with DR025) with a reported
PHD2 inhibitor ([1-chloro-4-hydroxyisoquinoline-3-carbonyl]-
amino)-acetic acid (Warshakoon et al., 2006) and with the
8-HQ-containing DR016 (10:1 ratio with DR025) (Table 1B).
These experiments provide evidence that this probe binds to
the PHD2 active site (Figure 1Aiii and 1Aiv). No crosslinking
was observed for the scaffold DR024 without the 8-HQ group
(Table 1B and Figure 1Av). The presence of metal was important
for efficient crosslinking (Figure 1Bii and 1Biii). The low level of
crosslinking in the absence of Mn(II) (Figure 1Bii) may be due
to residual Fe(II) in the PHD2 sample (McNeill et al., 2005). Using642–654, May 27, 2011 ª2011 Elsevier Ltd All rights reserved 643
Table 1. Structures and Biological Validation of Photoreactive Small-Molecule Probes Used in the Study
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DR031 625 mM No binding at 250 mM No inhibition at 300 mM
Chemistry & Biology
Photoreactive Probe for 2-Oxoglutarate Oxygenases
644 Chemistry & Biology 18, 642–654, May 27, 2011 ª2011 Elsevier Ltd All rights reserved
Table 1. Continued
DR025 58.5 mM 17.7 mM 41.8 mM
DR024
(scaffold)b
OH No inhibition at 300 mM No binding at 250 mM No inhibition at 300 mM
DR016
(competitor)
40.7 mM 0.7 mM 20.8 mM
aSee also Figures S1A–S1C.
bSee also Scheme S1.
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for the formation of a covalent adduct between DR025 and
PHD2 in protein mixtures containing additional enzymes (e.g.,
lysozyme, lactic dehydrogenase) unrelated to oxygenases
(Figure S2A).
The efficiency of crosslinking was investigated under condi-
tions of varying wavelengths, concentrations of the target and
the probe, incubation times, and buffer. After some optimization,
the following conditions were selected for further investigation:
20 min of irradiation at 365 nm with an energy of 5 mW/cm2,
conditions which led to 35% crosslinking relative to unmodified
protein (Figure S2B). This level is in agreement with reported dataFigure 1. Crosslinking between DR025 and PHD2 Is Dependent on Irra
(A) MALDI TOF MS spectra for photolabeling of PHD2181–426 by DR025. PHD2181
presence of Mn(II) (5 mM). After irradiation on ice (20 min, 365 nm), the resulting s
Results after irradiation in the presence of an inhibitor ([1-chloro-4-hydroxyisoquin
concentration ratio with DR025. (iv) Competition experiment with DR016 (250 mM)
and efficiency of PHD2 capture by DR025, see Figure S2.
(B) Effect of Mn(II) on the efficiency of PHD2181–426 capture by DR025. (i and iii) Effe
(5 mM) before and after irradiation, respectively. (ii) Effects of the irradiation on th
Chemistry & Biology 18,for phenyl azide-mediated photocrosslinking; incomplete cross-
linking is likely, at least in part, due to quenching of the reactive
intermediates by solvent/buffer (Fleming, 1995).
Photoaffinity Labeling and Enrichment of Purified 2-OG
Oxygenases
We then investigated the capability of the probe to enable enrich-
ment of a target protein by means of avidin-coated beads.
Following irradiation, the protein-probe mixture was incubated
with avidin-coated agarose beads; after washing, the beads
were then mixed with the MALDI matrix and analyzed; after the
affinity-purification step, there was enrichment of crosslinkeddiation and Mn(II)
–426 (5 mM) and DR025 (25 mM) were incubated (45 min, r.t.) in Tris buffer in the
olutions were analyzed by MS. (i and ii) Results before and after irradiation. (iii)
oline-3-carbonyl]-amino)-acetic acid (Warshakoon et al., 2006) (25 mM) in a 1:1
in a 10:1 molar ratio with DR025. (v) Control with DR024 (25 mM). For selectivity
cts relative to amixture in Tris buffer of PHD2 (5 mM), DR025 (25 mM), andMn(II)
e same mixture without Mn(II).
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Figure 2. Photoaffinity Labeling and Enrichment of Purified PHD2 by DR025
(A) MALDI TOFMS spectra for the crosslinking of purified PHD2181–426 by DR025. PHD2181–426 (5 mM) andDR025 (15 mM)were incubated (45min, r.t.) in Tris buffer
in the presence of Mn(II) (5 mM). After irradiation on ice (20 min, 365 nm) the solutions were divided, with one part being analyzed by MALDI TOF and the other
incubated (30 min, r.t.) with avidin-coated agarose beads. After washing (see Experimental Procedures), the beads were mixed with the MALDI matrix and
analyzed. (i) Before irradiation in the presence of DR025. (ii) After irradiation in the presence of DR025. (iii) After irradiation and avidin-bead-mediated purification.
(iv) After irradiation in the presence of DR024 at the same concentration (15 mM) as DR025 and affinity purification. For the identification of the PHD2 region
covalently crosslinked by DR025, see Figure 5 and the text.
(B) Magnification of the PHD2181–426 region of spectra in (A).
(C) MALDI TOF spectra of the crosslinking of PHD2181–426 by DR025 in the presence of HEK293T cell lysates. PHD2181–426 (5 mM, 5.2 mg), Mn(II) (5 mM), and DR025
(15 mM) were incubated (45 min, r.t.) in Tris buffer in the presence of HEK293T cell lysates (50 mg total protein). After UV treatment on ice (20 min, 365 nm) the
resulting solutions were divided, with one part being analyzed by MALDI TOF and the other incubated (30 min, r.t.) with avidin-coated agarose beads. After
washing, the beads were mixed with the MALDI matrix and spotted. (i) Before irradiation in the presence of DR025. (ii) After irradiation in the presence of DR025.
(iii) After irradiation and affinity purification in the presence of DR025. (iv) Same as (iii) but in the presence of DR024 at the same concentration (15 mM) as DR025.
(D) Magnification of the PHD2181–426 region of the spectra in (C).
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However, after crosslinking and affinity purification, unmodified
PHD2 was still observed (Figures 2Aiii and 2Biii); unmodified
PHD2 was also observed, to a small extent, after the same treat-
ment when using the scaffold DR024 (Figure 2Aiv). This is likely
due to relatively nonspecific capture of PHD2 by the beads at
the relatively high PHD2 concentrations used in these analyses
(see below). Note that the limit of detection by MALDI-TOF MS
requires protein concentrations (5 mM in this case) that are likely
higher than the endogenous levels of most proteins in biologi-
cally relevant samples.
We then carried out the analyses in the presence of HEK293T
cell lysates as a background to test whether the probe can selec-646 Chemistry & Biology 18, 642–654, May 27, 2011 ª2011 Elseviertively target proteins in a complex mixture. Comparison of the
spectra in Figure 2Ci–2Ciii shows that after affinity purification
there is selective enrichment of the tagged PHD2 over back-
ground proteins (indicated with an asterisk). A limitation of this
experiment was that the concentration of PHD2 was likely higher
(5 mM) as compared to other ‘‘background’’ proteins. As stated
above, this may account for some of the apparent nonspecific
capture observed (Figure 2Diii). Low levels of nonspecific
capture (but not crosslinking) were observed with the scaffold
control DR024 (Figure 2Civ).
Labeling of purified PHD2 (alone and when added to HEK293T
cell lysates) was also analyzed by simultaneous western blotting
using anti-biotin and anti-PHD2 antibodies. As indicated in theLtd All rights reserved
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of PHD2 by DR025 was apparent in both experiments and was
selective for PHD2 in the presence of the ‘‘background’’ proteins
of HEK293T cell lysates (Figure 3B, central). Crosslinking was
significantly reduced in the presence of a 10-fold excess of the
8-HQ competitor DR016 and absent in the control with the scaf-
fold DR024 and in the experiment without irradiation. The anti-
PHD2 blots confirmed that capture of PHD2 by DR025 was
substantially reduced in the presence of DR016, in controls
with the scaffold (DR024) alone, and without irradiation (Figures
3A and 3B, left). In the latter two experiments (i.e., DR024 alone
and without irradiation), as previously found (Figures 2A–2D),
a low level of nonspecific PHD2 capture was observed, as
demonstrated by comparison of the corresponding lanes in the
anti-biotin blots that show a complete absence of biotinylation
(Figures 3A, right, and 3B, central). It was notable that, compared
to those with isolated proteins, nonspecific PHD2 capture was
reduced in the experiments with cell lysates, probably because
of competition for ‘‘nonspecific’’ binding exerted by the other
proteins (compare corresponding lanes in the left panels of
Figures 3A and 3B). SDS-PAGE and silver staining (Figure 3B,
right) supported the capability of DR025 to selectively capture
PHD2 in the presence of irradiated HEK293T cell-lysate proteins
(Figure 3B, right). Identification of the labeled protein band at
28 kDa as the supplemented PHD2 was verified by LC-MS/MS
analysis (see Experimental Procedures).
We then tested the versatility of the probe for crosslinking
to 2-OG oxygenases by carrying out experiments with the
2-OG-dependent histone demethylase JMJD2E. Closely analo-
gous results to those obtained with PHD2 were obtained with
JMJD2E (Figures S3A and S3B), providing preliminary evidence
for the suitability of DR025 as a general probe for the 2-OG
oxygenase superfamily.
Validation of the Functional Probe by Detecting
Endogenous Levels of Target Proteins
To investigate the utility of DR025 in a more biologically relevant
context, we then carried out analyses of crude extracts prepared
from human HEK293T cells (grown under normoxic conditions)
that either overexpressed full-length PHD2 or were untrans-
fected (Figures 3C and 3D, respectively). TheMALDIMS analysis
method was not applicable, at least with our current capability,
because of the complexity of the system and the low abundance
of the target protein. In cell extracts from both untransfected and
PHD2-overexpressing HEK293T cells, anti-PHD2 immunoblot-
ting (Figures 3C and 3D, left) revealed PHD2 capture by
DR025. A strong reduction in capture was observed in competi-
tion experiments using DR016, and a complete absence of any
labeling was observed in controls with the inactive probe
DR014 or without irradiation. These controls imply that the
nonspecific capture observed at the high PHD2 concentrations
used in the preliminary analyses (Figures 2, 3A, and 3B) is not,
at least under the conditions tested, a problem when the target
concentration is at relatively low ‘‘endogenous’’ levels. It was
necessary to use a more sensitive chemiluminescence kit for
immunoblotting to observe the same degree of capture in the
lysates from the cells not overexpressing PHD2 than in those
doing so (see Experimental Procedures for details). The two
anti-biotin immunoblots (Figures 3C and 3D, right) showedChemistry & Biology 18,more than one band in the capture assay. Some of them were
substantially reduced or absent in the competition (DR016) and
scaffold (DR024) controls, indicating a specific enrichment of
more than one protein as a result of the crosslinking process
(see below). In the lanes with the input lysates and the experi-
ments without irradiation, we did not detect any bands even
from the naturally present biotinylated proteins, likely because
the lysate was subjected to a ‘‘preclearing’’ with avidin-coated
beads prior to probe treatment.
Mapping the PHD2 Probe Photocrosslinking Site
We then investigated the photocrosslinking site of the probe
DR025 with recombinant PHD2181–426 by performing photocros-
slinking followed by purification and tryptic digestion/MS anal-
ysis to map the region(s) that is covalently modified. LC-MS/
MS analysis of the digested photocrosslinked PHD2181–426
material revealed three coeluting precursor ion masses that
may contain crosslinked species (Figure 4A): (1) a doubly
charged ion at m/z = 817.42 Da (MW = 1632.84 Da) was identi-
fied by MS/MS analysis as VELNKPSDSVGKDVF (Figure 4B),
which corresponds to the C-terminal sequence of PHD2411–426;
(2) a triply charged precursor ion at m/z = 755.40 Da (MW =
2263.20 Da) exhibited the same fragmentation pattern under
normal MS/MS conditions as the ion at 817.42 Da (MW =
1632.84 Da), but with additional ions in the low molecular range
(Figure 4C); and (3) a singly charged ion at m/z = 631.35 Da
(MW = 630.35 Da) corresponding to the exact mass difference
(MW = 2263.20 – 1632.84 = 630.36 Da) between the ions at
755.40 Da (MW = 2263.20 Da) and 817.42 (MW = 1632.84 Da).
In theMS/MS spectrum of the precursor ion for the latter species
(817.42 Da), we did not observe proteotypic immonium ions,
suggesting that it is not derived from a proteotypic peptide (Fig-
ure S4). We compared the MS/MS spectra in the low molecular
range of all three precursor ions (Figure S4), and observed that
fragment ions derived from the precursor at 631.35 Da (MW =
630.35 Da) were also present in theMS/MS spectrum of the triply
charged precursor ion at 755.40 Da (MW = 2263.20 Da) but not
in the spectrum of the doubly charged precursor ion at
817.42 Da (MW = 1632.84 Da). These observations imply that
the C-terminal region of PHD2411–426 (VELNKPSDSVGKDVF) is
reacted with DR025. We noted that during the ionization, the
majority of the crosslinked peptides undergo fragmentation
releasing a nonproteotypic fragment (630.35 Da). To confirm
this, we produced an MS/MS spectrum of the precursor at
755.40 Da [M+3H]3+ (MW = 2263.20 Da) with reduced collision
energy (Figure 4D). Under these conditions, we observed only
a doubly charged fragment ion at 817.42 Da (MW = 1632.84
Da) and a singly charged ion at 631.35 Da (MW = 630.35 Da),
implying that the peptide does not (normally) fragment, and the
DR025-derived fragment at 631.35 Da is separated in an intact
form from the precursor ion at 755.40 Da (Figure 4D). Taken
together, the spectra show that the precursors at 755.40 Da
[M+3H]3+ (MW = 2263.20 Da) and 817.42 Da [M+2H]2+ (MW =
1632.84 Da) correspond to the same PHD2-derived peptide
with andwithout a linked nonproteotypic adduct with amolecular
weight of 630.35 Da. The precursor ion for the triply charged
adduct at 755.40 Da was not observed in the non-UV-irradiated
PHD2 protein control sample. The instability of the peptide-
probe adduct under MS/MS conditions did not allow the exact642–654, May 27, 2011 ª2011 Elsevier Ltd All rights reserved 647
Figure 3. Photoaffinity Labeling and Enrichment of Purified and Endogenous Human PHD2 by DR025
(A) Western blot analysis of the capture of purified PHD2181–426 by DR025. PHD2181–426 (5 mM, 5.2 mg) and DR025 (5 mM) were incubated in the presence of Mn(II)
(5 mM) at room temperature. After irradiation and purification by streptavidin-coated beads, proteins were separated by SDS-PAGE and analyzed by anti-PHD2
(polyclonal antibody from rabbit; left) and anti-biotin (right) immunoblotting. The input purified PHD2181–426 was 4% of the protein corresponding to the other
lanes. For an analogous experiment with JMJD2E, see Figure S3A.
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Figure 4. Identification by MS of the PHD2 Peptide Sequence Covalently Crosslinked by the Probe
(A) MS spectrum of PHD2181–426 covalently crosslinked by DR025. PHD2181–426 (5 mM),Mn(II) (5 mM), and DR025 (25 mM)were incubated (45min, r.t.) in Tris buffer.
After irradiation (20 min, 365 nm) and purification by means of streptavidin beads, photocrosslinked PHD2181–426 was digested on the beads with trypsin and
analyzed by LC-MS/MS.
(B) MS/MS spectrum of the doubly charged precursor ion atm/z = 817.42 Da. The doubly charged precursor ion atm/z = 817.42 Da was identified as the peptide
VELNKPSDSVGKDVF, which represents the C-terminal region of PHD2181–426. The b and y fragment ion series and the detected immonium ions are shown.
(C) MS/MS spectrum of the triply charged precursor ion atm/z = 755.40 Da. The triply charged precursor ion atm/z = 755.40 Da exhibits the same fragmentation
pattern as the coeluting precursor at m/z = 817.42 Da with additional ions in the low molecular mass range. The b and y fragment ion series and the detected
immonium ions are shown as in (B).
(D) MS/MS spectrum of the triply charged precursor ion atm/z = 755.40 Da with reduced collision energy. Under these conditions, the triply charged precursor
loses a singly charged fragment atm/z = 631.35 Da, which generates the doubly charged precursor atm/z = 817.42 Da (MW= 1632.84 Da). For MS/MS spectra in
the low molecular range of the precursor ion masses associated with the crosslinked PHD2, see Figure S4.
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results reveal a major site of crosslinking of the probe as the
C-terminal region of PHD2411–426.
Profiling of 2-OG Oxygenases in Human Cells
We investigated whether DR025 could be used to identify 2-OG
oxygenases present in a human cell line (HEK293T cells grown
under normoxic conditions) using MS (Wu and MacCoss,
2002). To differentiate between specifically enriched and
‘‘nonspecifically’’ captured proteins (see Table 2 and Experi-
mental Procedures for details), we compared the results ob-
tained from proteomic analyses in labeling experiments using
DR025 with controls, including proteomic analyses of the di-
gested input lysate. The identified 2-OG oxygenases were(B) Immunoblotting and silver-staining analysis showing capture of purified PHD2
from rabbit; left), anti-biotin (center), and silver-stained SDS-PAGE gels (right) are
the presence of HEK293T cell lysates (43 mg total proteins). The input lysate
corresponding to the other lanes; the purified PHD2181–426 as standard was 4%
with JMJD2E, see Figure S3B.
(C) Crosslinking with full-length PHD2 in HEK293T cell lysates overexpressing full
lysate overexpressing human full-length PHD2 (40 mg total protein). After UV tr
beads, proteins released from the beads were analyzed by SDS-PAGE and weste
(right) antibodies. The input lysate overexpressing full-length PHD2 was 2% of
(D) Crosslinking of endogenous full-length PHD2 in HEK293T cell lysates (i.e., no
lysates (200 mg total protein) not overexpressing PHD2. The input lysate was 
Chemistry & Biology 18,divided into three groups on the basis of the controls: enrich-
ment, possible enrichment, and no enrichment. There was clear
evidence for enrichment of PHD2 (Epstein et al., 2001) for two
N3-methyl histone lysyl demethylases, JARID1C (Jensen et al.,
2005) and FBXL11(Tsukada et al., 2006), and for the collagen
lysyl hydroxylase LH3 (Risteli et al., 2009). These oxygenases
were identified only in the labeling experiment with DR025, that
is, they were not identified in the DR016 competition control or
in the other controls (scaffold DR024 and no irradiation). In the
cases of PHD2 and LH3, we did not accrue evidence for them
in the input lysate. For two other oxygenases, TET2 (Loenarz
and Schofield, 2009) and the N3-methyl histone lysyl demethy-
lase PHF8 (Yu et al., 2010), we observed evidence for possible
enrichment due to their identification when captured by the181–426 by DR025 in HEK293T cell lysates. The anti-PHD2 (polyclonal antibody
relative to an experiment carried out under the same conditions as in (A) but in
supplemented with recombinant PHD2181–426 was 4% of the total protein
of the protein corresponding to the other lanes. For an analogous experiment
-length PHD2. DR025 (10 mM) was incubated (45 min, r.t.) with an HEK293T cell
eatment (20 min, 365 nm) and purification by means of avidin-coated agarose
rn blots using anti-PHD2 (monoclonal antibody frommouse; left) and anti-biotin
the total protein corresponding to the other lanes.
t overexpressing PHD2). Conditions are as in (C) but employing HEK293T cell
3% of the total protein corresponding to the other lanes.
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Table 2. 2-OG Oxygenases Identified by DR025 in HEK293T Cell Lysates
ID
2-OG
Oxygenase
DR025 (Probe) DR016 (Competition) DR024 (Scaffold) No Irradiation Lysate (Input)
Resulta
Spectral
Countsb
Number
of
Peptidesc
Coverage
(%)d
Spectral
Counts
Number
of
Peptides
Coverage
(%)
Spectral
Counts
Number of
Peptides
Coverage
(%)
Spectral
Counts
Number
of
Peptides
Coverage
(%)
Spectral
Counts
Number
of
Peptides
Coverage
(%)
Q9GZT9 PHD2e 2 1 4 Absent Absent Absent Absent E
P41229 JARID1C
(KDM5C)
2 2 1 Absent Absent Absent 5 5 2 E
Q9Y2K7 FBXL11e
(KDM2A)
1 1 0.9 Absent Absent Absent 8 7 6 E
O60568 LH3 2 1 2 Absent Absent Absent Absent E
Q6N021 TET2 2 2 1 9 9 4 Absent Absent Absent PE
Q9UPP1 PHF8 2 2 2 11 7 3 Absent Absent Absent PE
Q15652 JMJD1C 5 1 0.6 27 14 5 21 14 5 29 20 8 22 14 7 NE
Q9UGL1 JARID1B
(KDM5B)
1 1 1 8 8 6 11 11 7 Absent 6 5 2 NE
O94953 JMJD2B
(KDM4B)
4 2 2 18 8 7 Absent 11 8 6 Absent NE
DR025 (10 mM) was incubated with a whole lysate from HEK293T cells grown under normoxic conditions (950 mg total protein, 45 min, r.t.). After irradiation (20 min, 365 nm) and purification by
avidin-coated agarose beads, trypsin digestion and LC-MS/MS analysis comparison with the human protein database were performed. The columns reflect the following conditions. DR025 (probe),
complete experiment in the presence of DR025. No Irradiation, same as DR025 but without UV treatment. DR024 (scaffold), negative control experiment in the presence of scaffold DR024 (10 mM).
DR016 (competitor), control experiment with the competitor DR016 (200 mM) in a 20:1 molar ratio with DR025. Lysate, input lysate (5% of the total protein corresponding to the other columns). Note
that detection corresponds to the observation of at least one peptide with the correct predicted mass for the identified oxygenases. See also Table S1.
a E, enrichment; enzyme not detected in the DR024 and No Irradiation negative controls. PE, possible enrichment; enzyme not detected in the DR024 and No Irradiation negative controls, but de-
tected with the DR016 competitor control. NE, no enrichment; enzyme detected in at least one of the negative controls (DR024 or No Irradiation).
b Spectral counts: number of MS/MS spectra identified.
cNumber of unique peptides identified by MS/MS.
dProtein sequence coverage (%).
eConfirmed by immunoblotting (Figures 3 and 4).
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Figure 5. Photoaffinity Crosslinking Experiments in Lysates from HEK293T Cells Grown under Normoxic and Hypoxic Conditions
(A) Crosslinking of endogenous FBXL11 (KDM2A) in nuclear protein extracts of HEK293T cells. DR025 (10 mM) was incubated (45 min, r.t.) with nuclear extracts
(200 mg total protein) of HEK293T cells grown under normoxic (left) and hypoxic (right) conditions. After irradiation (20 min, 365 nm) and purification with
streptavidin beads, the proteins released were analyzed by SDS-PAGE and subsequent anti-FBXL11 (polyclonal antibody from rabbit) immunoblotting. The
reference protein was a nuclear protein extract of HEK293T cells overexpressing FBXL11 (KDM2A). For the entire immunoblot, see Figure S5A.
(B) Crosslinking of PHD3 at endogenous levels in HEK293T cell lysates. DR025 (10 mM) was incubated (45 min, r.t.) with cell lysates (200 mg total protein) of
HEK293T cells grown under normoxic (left) and hypoxic (right) conditions. After irradiation (20 min, 365 nm) and purification by streptavidin beads, released
proteins were analyzed by SDS-PAGE and anti-PHD3 (monoclonal antibody from mouse) immunoblotting. The protein reference was a cell lysate (RCC4)
overexpressing PHD3. For the entire immunoblot, see Figure S5B.
(C) Identification of endogenousHIF-1a in HEK293T cell lysates. DR025 (10 mM)was incubated (45min, r.t.) with a whole lysate (200 mg total protein) of HEK293T
cells grown under normoxic (left) and hypoxic (1%O2) (right) conditions. After irradiation (20min, 365 nm) and purification by streptavidin beads, released proteins
were analyzed by SDS-PAGE and anti-HIF-1a (monoclonal antibody from mouse) immunoblotting. The input HEK293T lysate was 3% of the total protein
corresponding to the other lanes; the protein reference was a cell lysate (RCC4) overexpressing HIF-1a. For the entire immunoblot, see Figure S5C.
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Photoreactive Probe for 2-Oxoglutarate Oxygenasesprobe (DR025), but both were absent in the scaffold, no irradia-
tion, and input lysate controls. They were, however, observed in
the competition (DR016) control experiments, but we cannot rule
out the possibility that this is because of incomplete competition.
Three 2-OG oxygenases were considered as likely not enriched
because they were identified in at least one of the scaffold or no
irradiation controls (Table 2).
Overall, the MS results suggest that appropriately functional-
ized probes can capture and enrich endogenous levels of
PHD2 and other 2-OG oxygenases. However, the identified
2-OG oxygenases had a low number of spectral counts relative
to background proteins, which is in part due to the fact that
these enzymes are not expressed at abundant levels in cells.
Hence, to further validate the approach, we employed western
blotting to confirm the enrichment of at least one 2-OG oxygen-
ase other than PHD2. We focused our attention on the histone
demethylase FBXL11 (KDM2A), an enzyme involved in epige-
netic regulation (Tsukada et al., 2006). As shown Figure 5A
(see also Figure S5A), western blotting demonstrated that theChemistry & Biology 18,probe was able to specifically capture FBXL11 in nuclear
extracts of HEK293T cells grown under both normoxic condi-
tions and, to a greater extent, hypoxic conditions. The results
with FBXL11 are important because they reveal the potential of
the method to profile 2-OG oxygenase inhibitors.
To test whether 8-HQ is indeed an inhibitor of FBXL11
(KDM2A), we produced FBXL11 in a recombinant form and
carried out tests using an assay that monitors formaldehyde
production (see Experimental Procedures). The results revealed
inhibition of FBXL11 with IC50 values in the micromolar range
(IC50 = 9.1 mM for DR016 and IC50 = 16.7 mM for DR025; Fig-
ure S1D), but a lack of inhibition by the scaffold control DR024
(no inhibition at 100 mM). These results reveal the potential of
the method for profiling 2-OG oxygenase inhibitors.
Discrimination between Different Levels of PHD3
Expression Depending on Oxygenation Conditions
The finding that FBXL11 (KDM2A) was more efficiently captured
by DR025 under hypoxic than normoxic conditions (Figure 5A;642–654, May 27, 2011 ª2011 Elsevier Ltd All rights reserved 651
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Photoreactive Probe for 2-Oxoglutarate OxygenasesFigure S5A) led us to test the capability of the probe to discrim-
inate between different target protein expression levels under
different oxygenation conditions. We chose to analyze PHD3,
which is known to be strongly induced by hypoxia in some cell
lines (Pescador et al., 2005, Pollard et al., 2008; Appelhoff,
et al., 2004). The anti-PHD3 immunoblot in HEK293T whole-
cell lysates prepared under normoxic or hypoxic conditions
clearly showed that the probe DR025 (or a derivative thereof)
is a valid tool to detect the difference of expression between
normoxic and reduced oxygenation conditions (Figure 5B; Fig-
ure S5B). On the basis of this evidence and studies on the inhibi-
tion of histone demethylation by 8-HQderivatives, DR025 can be
proposed as a potentially useful probe to profile different expres-
sion levels of 2-OG oxygenases in tissues.
Detection of the 2-OG Oxygenase PHD2 Substrate
HIF-1a at Endogenous Levels
Althoughwe cannot rule out the possibility of other sites of cross-
linking, the demonstration that the C terminus of PHD2 is
involved is interesting because this region interacts with its
HIF-a substrate (Chowdhury et al., 2009). The available evidence
suggests the extent to which PHD inhibitors block HIF-a
substrate binding varies (Chowdhury et al., 2009). We therefore
considered whether DR025 might be capable of ‘‘capturing’’
the HIF-a substrate of the PHDs along with the enzymes. As
shown by anti-HIF-1a western blotting (Figure 5C; Figure S5C),
DR025 is capable of capturing (by an unknown mechanism),
albeit not strongly, endogenous levels of HIF-1a in HEK293T
cell lysates at least when cultured under hypoxic conditions,
where HIF-1a levels are increased relative to normoxic condi-
tions (Figure 5C) (Kaelin and Ratcliffe, 2008).
DISCUSSION
Overall, the results demonstrate the potential of a small-mole-
cule probe-based approach for identifying 2-OG oxygenases in
crude cell extracts via photocrosslinking and affinity purification
coupled to MS analysis. Importantly, we were able to demon-
strate that the probe is able to capture human 2-OG oxygenases
in cell extracts at endogenous levels (Figures 3D and 5). Thus,
with appropriate development, such as by optimization of the
active site binding groups and crosslinking conditions, the pho-
tocrosslinking probe method could be used for profiling 2-OG
oxygenases from different cell types. This application is poten-
tially useful for (patho)physiological analysis because levels of
some 2-OG oxygenases (e.g., JMJD2C and PHD3) vary in
diseased and hypoxic cells (Pollard et al., 2008). DR025 showed
the capability to discriminate between different levels of expres-
sion of PHD3 and, to a lesser extent, of FBXL11 (KDM2A) in
lysates from cells (HEK293T) grown under normoxic and hypoxic
conditions (Figures 5A and 5B). These results support work
showing that some 2-OG oxygenases, including PHD3 and
JMJD1A (Pollard et al., 2008), are induced by hypoxia.
Modifications of our lead probe designed to enable cell pene-
tration by introducing postlysis an affinity-purification tag via
‘‘click’’ chemistry or other ligation techniques are possible, as
reported in work on probes for proteases (Sadaghiani et al.,
2007; Sieber et al., 2006). Although it is unlikely that DR025 itself
will be a useful probe for all human 2-OG oxygenases, our results652 Chemistry & Biology 18, 642–654, May 27, 2011 ª2011 Elseviersuggest that it may be useful for a significant subset. In principle,
the probe approach could also be useful for identifying enzymes
from the superfamily not already annotated as2-OGoxygenases.
Various 2-OG oxygenases are being targeted for therapeutic
intervention. g-butyrobetaine hydroxylase is a target for the
clinically used compound mildronate (Liepinsh et al., 2006), and
HIF-ahydroxylasesandhistonedemethylasesarebeingexplored
as targets for anemia/ischemic diseases and cancer, respec-
tively.Oneapplication of theprobemethodologymaybe toprofile
oxygenases that a particular inhibitor/modulator targets inside
a cell, including ‘‘off-target’’ interactions of lead compounds.
One problem with this approach is that a modification of a ‘‘small
molecule’’ with relatively largephotocrosslinking/affinity-purifica-
tion groups will inevitably modify binding characteristics, poten-
tially leading to false-negative results. However, given the high
cost of pharmaceutical development, the effort of applying this,
or related approaches, to potential leads in order to identify
potentially deleterious interactions would seem to be small.
In support of the approach, we found that DR025 crosslinked
to the histone demethylase FBXL11 (KDM2A) in HEK293T cell
lysates, as initially identified by MS analysis (Table 2) and
confirmed by antibody analysis (Figure 5A). We subsequently
demonstrated that DR025 and the 8-HQ derivative which acts
as a selectivity function (DR016) actually inhibit FBXL11
(KDM2A) to a significant extent (IC50 = 16.7 mM for DR025 and
IC50 = 9.1 mM for DR016). To our knowledge, this is the first
reported inhibition study on FBXL11 (KDM2A) and supports the
proposal that 8-HQs may be useful generic templates for the
inhibition of 2-OG oxygenases (King et al., 2010).
Finally, we note that the photocrosslinking approachmay have
applications for functional assignment studies of 2-OG oxy-
genases and other enzymes. Analyses on purified PHD2 after
crosslinking and affinity purification with DR025 demonstrate
that crosslinking occurs between DR025 and the C-terminal
region of PHD2411–426 (Figure 4; Figure S4). The C terminus of
PHD2 is involved in HIF-a substrate binding (Chowdhury et al.,
2009). This suggests that the probe may be useful in ‘‘capturing’’
a substrate from the cell extract. Indeed, western blotting anal-
yses revealed that HIF-1a was purified along with PHD2 at least
from whole lysates of HEK293T cells cultured under hypoxic
conditions (Figure 5C; Figure S5C), consistent with the reported
reduced degradation of HIF-1a under hypoxia. This preliminary
evidence of an active site-directed probe capable of identifying
endogenous levels of the natural substrate of a target enzyme,
on the basis of our knowledge, is one of the first reported to
date. As for the crosslinking to PHD2 itself, the mechanism of
the apparent crosslinking to HIF-1a is uncertain; however, anal-
ysis of a PHD2-substrate structure (Chowdhury et al., 2009)
suggests that it is possible that it occurs by crosslinking of the
probe with HIF-1a that is simultaneously bound to PHD2. An
application of the chemical probe strategy reported here may
therefore be to identify (new) substrates for 2-OG oxygenases
(or indeed other protein interactors).
SIGNIFICANCE
2-Oxoglutarate (2-OG)-dependent oxygenases catalyze a
range of hydroxylation and N-methyl demethylation reac-
tions that are important in oxygen sensing and theLtd All rights reserved
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Photoreactive Probe for 2-Oxoglutarate Oxygenasesepigenetic control of gene expression. These enzymes are
being targeted for modulation by small molecules as novel
potential therapeutic targets for the treatment of anemia,
ischemic diseases, and cancer. We demonstrate that a
small-molecule probe-based approach employing photo-
crosslinking and affinity purification is useful for the identifi-
cation of 2-OG oxygenases present in human cell extracts
and for identifying 2-OG oxygenases that interact with inhib-
itors. The approach was validated by studies on a transcrip-
tion factor hydroxylase (PHD2, EGLN1) and by the finding
that the probe binds to and inhibits the N3-methyl lysine
histone demethylase FBXL11 (KDM2A). We also demon-
strate the potential of this photocrosslinking small-molecule
probe-based approach to ‘‘capture’’ the 2-OG oxygenase
(PHD2) substrate HIF-1a, suggesting that it may be useful
in substrate capture and discovery studies.
EXPERIMENTAL PROCEDURES
Synthesis of Probes
Details of the synthesis of the probes DR014, DR031, and DR025 are given in
Supplemental Experimental Procedures, along with analytical data. The PHD2
inhibitor ([1-chloro-4-hydroxyisoquinoline-3-carbonyl]-amino)-acetic acid was
synthesized as reported (Stubbs et al., 2009).
Photocrosslinking Experiments
The photocrosslinking procedure is described here for purified PHD2181–426
and DR025. For the other purified enzyme, JMJD2E, experiments in the pres-
ence of non-2-OG enzymes (Figure S2A), experiments with HEK293T whole-
cell lysates as background, and tests in the presence of HEK293T whole-cell
lysates or nuclear protein extracts, capture was performed in an analogous
manner. PHD2181–426 (5 mM) and MnCl2 (5 mM) were incubated with DR025
(25 mM) in Tris buffer (50 mM Tris, 100 mM NaCl [pH 7.4]) with shaking at
room temperature (r.t.) (45 min). The samples were then irradiated (20 min)
on ice with UV light at 365 nm at an irradiance of 5 mW/cm2 (Spectrolinker
XL-1500). Controls in the presence of the scaffold DR024 or of the competitive
inhibitor DR016 were treated in the same way. After exposure to UV light, the
samples were either directly analyzed by MALDI-TOF MS or subjected to
purification using (strept)avidin-coated beads.
Affinity-Purification Experiments
The complete labeling and enrichment procedure is described here for purified
PHD2181–426 and the probe (DR025) in the presence of HEK293T cell lysates. In
experiments with purified enzymes and in the presence of only HEK293T
whole-cell lysates or nuclear protein extracts, the labeling and enrichment
processes were performed in an analogous way. PHD2181–426 (7.5 ml of
25 mM in Tris buffer solution, final concentration 5 mM) and MnCl2 (1.5 ml of
125 mM in water, final concentration 5 mM) were incubated with DR025
(1.5 ml of 125 mM in water, final concentration 5 mM) in the presence of 27 ml
of HEK293T whole-cell lysates (1.6 mg/ml total protein) with shaking at r.t. for
45 min. The scaffold (DR024) control sample was prepared in the same way.
The mixture was then UV irradiated as described above, and incubated with
streptavidin-coated magnetic beads (50 ml; Dynabeads MyOne Streptavidin
C1; Invitrogen) for 30 min at r.t. in a shaker incubator. The beads were
collected using a magnetic device (Dynal DynaMag Spin; Invitrogen) and
washed five times with washing buffer (10 mM HEPES [pH 7.2], 1 M NaCl,
1% Triton X-100, 2 mM EDTA, 4 mM dithiothreitol) and then three times with
water. In other experiments, after the photocrosslinking, the mixtures were
incubated with avidin-coated agarose beads (Pierce monomeric avidin
agarose; Thermo Scientific). In these cases, the washing was performed
with the same buffer but without any device, and the supernatant was removed
by pipetting. Beads were stored at 20C.
In the experiments aimed at labeling and enriching endogenous levels of
target proteins, the final concentrations of probe (DR025) and scaffold control
(DR024) were 10 mM and the total protein amounts in the HEK293T whole-cellChemistry & Biology 18,lysates and in the nuclear protein extracts were 200 mg. In the capture exper-
iment carried out on the lysate obtained from HEK293T cells overexpressing
PHD2 the total protein amount was 40 mg, whereas in the profiling of the
2-OG oxygenases present in the HEK293T whole-cell lysates the total quantity
of proteins was 950 mg per sample in the presence of 10 mM DR025 and
DR024. The competition control tests were performed using the competitive
inhibitor DR016 (final concentration 10 or 40 times higher than DR025) (see
figure legends for details). Negative control experiments were carried out
by incubating with DR025 under the same conditions as the ‘‘capture’’ exper-
iments but without irradiation.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
five figures, and two tables and can be found with this article online at
doi:10.1016/j.chembiol.2011.03.007.
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